Newron Pharmaceuticals SpA (NWRN) — Cash Flow Reinvestment Rate
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting CHF31.00K (capex CHF31.00K ) from operating cash flow of CHF33.35 Million. Explore Newron Pharmaceuticals SpA (NWRN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Newron Pharmaceuticals SpA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Newron Pharmaceuticals SpA across 2 annual periods. Also explore NWRN current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year capital reinvestment analysis for Newron Pharmaceuticals SpA. For live market cap and broader valuation context, see market value of Newron Pharmaceuticals SpA.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF13.66 Million | CHF32.56 Million | CHF47.30K | ▲ +22121.3% |
| 2012 | 0.00x | CHF11.00K | CHF5.83 Million | CHF11.00K | — |